A study of the analytical behaviour of selected new molecular entities using electrospray ionisation ion trap mass spectrometry, liquid chromatography, gas chromatography and polarography and their determination in serum at therapeutic concentrations.

[1]  Xiaoyan Chen,et al.  Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of rosuvastatin in human plasma: application to a pharmacokinetic study. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  W. Haefeli,et al.  Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma. , 2007, Rapid communications in mass spectrometry : RCM.

[3]  H. Rosing,et al.  Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liq , 2007, Rapid communications in mass spectrometry : RCM.

[4]  Qian Jiang,et al.  Quantitative determination of rosuvastatin in human plasma by ion pair liquid-liquid extraction using liquid chromatography with electrospray ionization tandem mass spectrometry. , 2007, Journal of pharmaceutical and biomedical analysis.

[5]  J. Schellens,et al.  Liquid chromatography-tandem mass spectrometric assay for the nucleoside reverse transcriptase inhibitor emtricitabine in human plasma. , 2007, Biomedical chromatography : BMC.

[6]  N. Srinivas,et al.  Determination of rosuvastatin in rat plasma by HPLC: Validation and its application to pharmacokinetic studies. , 2006, Biomedical chromatography : BMC.

[7]  B. Jiang,et al.  Quantitative determination of rosuvastatin in human plasma by liquid chromatography with electrospray ionization tandem mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.

[8]  Nuggehally R Srinivas,et al.  Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies. , 2006, Biomedical chromatography : BMC.

[9]  Don E. Smith,et al.  Atazanavir Plasma Concentrations Vary Significantly Between Patients and Correlate with Increased Serum Bilirubin Concentrations , 2006, HIV clinical trials.

[10]  S. Oka,et al.  Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatography. , 2006, Biomedical chromatography : BMC.

[11]  K. Resch,et al.  Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[12]  R. Trivedi,et al.  Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC-MS/MS with electrospray ionization: assay development, validation and application to a clinical study. , 2005, Journal of pharmaceutical and biomedical analysis.

[13]  A. Jimeno,et al.  Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[14]  J. Poirier,et al.  Simple and Simultaneous Determination of the HIV-Protease Inhibitors Amprenavir, Atazanavir, Indinavir, Lopinavir, Nelfinavir, Ritonavir and Saquinavir Plus M8 Nelfinavir Metabolite and the Nonnucleoside Reverse Transcriptase Inhibitors Efavirenz and Nevirapine in Human Plasma by Reversed-Phase Liqu , 2005, Therapeutic drug monitoring.

[15]  B. Matuszewski,et al.  Simultaneous determination of Aprepitant and two metabolites in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection. , 2004, Journal of pharmaceutical and biomedical analysis.

[16]  T. Kaneda,et al.  A simple HPLC method for simultaneous determination of lopinavir, ritonavir and efavirenz. , 2003, Chemical & pharmaceutical bulletin.

[17]  F. Aweeka,et al.  Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS. , 2002, Journal of pharmaceutical and biomedical analysis.

[18]  M. Kris,et al.  Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  S. A. White,et al.  Rapid determination of gemifloxacin in human plasma by high-performance liquid chromatography-tandem mass spectrometry. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[20]  S. Oliver,et al.  Pharmacokinetics and Tolerability of Gemifloxacin (SB-265805) after Administration of Single Oral Doses to Healthy Volunteers , 2000, Antimicrobial Agents and Chemotherapy.

[21]  G. Tortora,et al.  Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  M. Kris,et al.  Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group. , 1999, The New England journal of medicine.